This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Falt, I. C. Articles by Lindberg, A. A. Search for Related Content PubMed PubMed Citation Articles by Falt, I. C. Articles by Lindberg, A. A.

 Previous Article  |  Next Article 

J. Bacteriol., 09 1995, 5310-5315, Vol 177, No. 18
Copyright © 1995, American Society for Microbiology

Expression of Shigella dysenteriae serotype 1 O-antigenic polysaccharide by Shigella flexneri aroD vaccine candidates and different S. flexneri serotypes

IC Falt, EK Schweda, S Klee, M Singh, E Floderus, KN Timmis and AA Lindberg
Department of Immunology, Microbiology, Pathology, and Infectious Diseases, Karolinska Institute, Huddinge, Sweden.

The potential utility of Shigella flexneri aroD vaccine candidates for the development of bi- or multivalent vaccines has been explored by the introduction of the genetic determinants rfp and rfb for heterologous O antigen polysaccharide from Shigella dysenteriae serotype 1. The serotype Y vaccine strain SFL124 expressed the heterologous antigen qualitatively and quantitatively well, qualitatively in the sense of the O antigen polysaccharide being correctly linked to the S. flexneri lipopolysaccharide R3 core oligosaccharide and quantitatively in the sense that typical yields were obtained, with ratios of homologous to heterologous O antigen being 4:1 for one construct and 1:1 for another. Moreover, both polysaccharide chains were shown to be linked to position O-4 of the subterminal D-glucose residue of the R3 core. In contrast to the hybrid serotype Y SFL124 derivatives, analogous derivatives of serotype 2a vaccine strain SFL1070 did not elaborate a complete heterologous O antigen. Such derivatives, and analogous derivatives of rough, O antigen-negative mutants of SFL1070, formed instead a hybrid lipopolysaccharide molecule consisting of the S. flexneri lipid A R3 core with a single repeat unit of the S. dysenteriae type 1 O antigen. Introduction of the determinants for the S. dysenteriae type 1 O antigen into a second serotype 2a strain and into strains representing other serotypes of S. flexneri, revealed the following for the expression of the heterologous O antigen: serotypes 1a, 1b, 2a, and 5a did not produce the heterologous O antigen, whereas serotypes 2b, 3a, 3b, 4a, 4b, 5b, and X did.

This article has been cited by other articles:

• Venkatesan, M. M., Hartman, A. B., Newland, J. W., Ivanova, V. S., Hale, T. L., McDonough, M., Butterton, J. (2002). Construction, Characterization, and Animal Testing of WRSd1, a Shigella dysenteriae 1 Vaccine. Infect. Immun. 70: 2950-2958 [Abstract] [Full Text]